““Carecubes offer the greatest potential for high-impact, sustainable implementation with minimal training. The modest footprint and modular nature of the design supports all transmission-based precautions in a setting where dedicated rooms, particularly airborne infection isolation rooms may not be available.”
”
Features
Two “lean-in glove walls” allow for rapid patient access.The Hugsuit, a full isolation suit built into the side of the Carecube, to provide deeper connection, care and touch.
Two intake filters ensure clean air enters the Carecube, while a HEPA filter cleans air on the way out, allowing for same-room recirculation.
Negative pressure and 15 air exchanges per hour that exceeds the CDC’s standard for AIIRs.
Conduit panels for IV tubing, electrical wires, and ventilator tubing interface all stay outside the Carecube for safe and easy access and adjustment.
Pass-through panels so procedure kits, meals, books, handheld devices can easily and safely move from outside to inside and vice-versa.
Designed and manufactured in the USA.
Efficient care with maximum protection for hospital operation.
Assembled and built in 20 minutes.
Highly cost-effective creation of negative pressure isolation capabilities.
Rapid care of patients without the rigors and exhaustion of PPE donning and doffing.
More easily and rapidly convert to manage infectious disease influx while maintaining typical operations.
Human factors testing shows the Carecube integrates into the standard of care.
0% increase in patient anxiety
A key tool for infectious disease response
The Carecube’s portability makes it easily transportable to make an impact in hours, not days.
Rapid and responsive deployment of negative-pressure isolation capabilities at any time and place.
2’ x 2’ x 4’ box for easy warehousing, transportation and storage.
Sets up in 20 minutes or less.
Allows for expansion of isolation capabilities at hospitals, while also creating a network of negative pressure isolation in community settings to protect highly-vulnerable populations.
Highly cost-effective for alternative care sites.
* The Carecube is under review for FDA Emergency Use Authorization during the COVID-19 public health emergency. It is not FDA cleared or approved and is not currently commercially available in the U.S.
